Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

AstraZeneca upgrade (of sorts) by leading investment bank

Published 16/04/2024, 12:22
© Reuters AstraZeneca upgrade (of sorts) by leading investment bank

Proactive Investors - AstraZeneca PLC (LON:AZN) has been upgraded by a leading investment bank following guidance on the company's dividend policy and a more positive earnings outlook.

Deutsche Bank (ETR:DBKGn) has moved to 'hold' from 'sell' on stock in the pharma giant as well as raising its price target by 1,00p to 10,500p.

The new target price reflects a forward price-to-earnings (P/E) ratio of 17 times for the fiscal year 2024 estimates.

While slightly more bullish, Deutsche still has ongoing questions regarding AZ's innovation and growth strategy, and around its approach to expansion via bolt-on acquisitions.

Mirroring the broader market trend, AZ's stock was off 0.8% at 10,935.59p.

Read more on Proactive Investors UK

Disclaimer

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.